Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL612550 | 0.83 | — | — | |
| SCHEMBL375599 | 0.78 | LMNA (0.35) | LMNATHRB | |
| SCHEMBL731628 | 0.77 | MAPK1 (0.31) | — | |
| SCHEMBL10969309 | 0.77 | — | — | |
| SCHEMBL22346066 | 0.77 | LMNA (0.41) | LMNATHRB | |
| SCHEMBL56821 | 0.74 | THRB (0.38) | LMNATHRB | |
| SCHEMBL734012 | 0.71 | THRB (0.39) | LMNATHRB | |
| SCHEMBL55696 | 0.70 | THRB (0.35) | LMNATHRB | |
| SCHEMBL8464619 | 0.69 | — | — | |
| SCHEMBL9241853 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138365-B2 | Method for producing organosilanes | EVONIK DEGUSSA GMBH (DE) | 2012-03-20 | — | — | US | claimed |
| US-20100217026-A1 | Method for producing organosilanes | EVONIK OPERATIONS GMBH (DE) | 2010-08-26 | — | — | US | claimed |
| EP-2057172-B1 | METHOD FOR PRODUCING ORGANOSILANES | EVONIK DEGUSSA GMBH (DE) | 2013-09-11 | — | — | EP | disclosed |
| CN-101511848-B | Method for producing organosilanes | EVONIK DEGUSSA GMBH | 2012-08-29 | — | — | CN | disclosed |
| US-8138365-B2 | Method for producing organosilanes | EVONIK DEGUSSA GMBH (DE) | 2012-03-20 | — | — | US | disclosed |
| US-20100217026-A1 | Method for producing organosilanes | EVONIK OPERATIONS GMBH (DE) | 2010-08-26 | — | — | US | disclosed |
| CN-101511848-A | Method for producing organosilanes | EVONIK DEGUSSA GMBH (DE) | 2009-08-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100217026-A1 | Method for producing organosilanes | TST, STS, HAO2 | LMNA 4751/4885THRB 2259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.